Jiping P. Zeng

Urology
222 E 41st St
New York, NY 10017

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Clinical stage IIA/B embryonal carcinoma predominant nonseminomatous germ cell tumor: Minimizing treatment burden.

Clinical stage IIA/B embryonal carcinoma predominant nonseminomatous germ cell tumor: Minimizing treatment burden.

Journal: Urologic oncology
Published: November 06, 2025

Diagnostic Accuracy of Circulating Tumor DNA to Predict Retroperitoneal Histology in Patients Treated With Retroperitoneal Lymph Node Dissection for Testicular Germ Tumor.

Diagnostic Accuracy of Circulating Tumor DNA to Predict Retroperitoneal Histology in Patients Treated With Retroperitoneal Lymph Node Dissection for Testicular Germ Tumor.

Journal: European urology
Published: August 24, 2025

Histologic Concordance Between Post-chemotherapy RPLND and Orchiectomy When Performed Simultaneously: Insights Into the Blood-testis Barrier.

Histologic Concordance Between Post-chemotherapy RPLND and Orchiectomy When Performed Simultaneously: Insights Into the Blood-testis Barrier.

Journal: Urology
Published: June 19, 2025

Comparison of 4 local anesthetic techniques for open radical cystectomy: A prospective, randomized controlled trial.

Comparison of 4 local anesthetic techniques for open radical cystectomy: A prospective, randomized controlled trial.

Journal: Urologic oncology
Published: April 15, 2025

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology
Published: March 25, 2025

Retroperitoneal Nodal Distribution for Metastatic Seminoma: Is Modified Template Appropriate? A Retrospective Study.

Retroperitoneal Nodal Distribution for Metastatic Seminoma: Is Modified Template Appropriate? A Retrospective Study.

Journal: The Journal of urology
Published: February 20, 2025

Screening and Studying of Blood miRNAs as Potential Diagnostic Markers for Papillary Thyroid Carcinoma.

Screening and Studying of Blood miRNAs as Potential Diagnostic Markers for Papillary Thyroid Carcinoma.

Journal: OncoTargets and therapy
Published: September 12, 2024

Retroperitoneal Lymph Node Dissection: Perioperative Management and Updates on Surgical Techniques.

Retroperitoneal Lymph Node Dissection: Perioperative Management and Updates on Surgical Techniques.

Journal: The Urologic clinics of North America
Published: June 26, 2024

Clinical registries in upper tract urothelial carcinoma: commitment to collaboration.

Clinical registries in upper tract urothelial carcinoma: commitment to collaboration.

Journal: Translational andrology and urology
Published: April 15, 2023

Gender, Racial and Ethnic Differences in Pathologic Response Following Neoadjuvant Chemotherapy for Bladder Cancer Patients.

Gender, Racial and Ethnic Differences in Pathologic Response Following Neoadjuvant Chemotherapy for Bladder Cancer Patients.

Journal: Urology
Published: January 05, 2023

Gemcitabine as first-line therapy for high-grade non-muscle invasive bladder cancer: results from a tertiary center in the contemporary BCG-shortage era.

Gemcitabine as first-line therapy for high-grade non-muscle invasive bladder cancer: results from a tertiary center in the contemporary BCG-shortage era.

Journal: Translational andrology and urology
Published: November 22, 2022

High-fat diet plus HNF1A variant promotes polyps by activating β-catenin in early-onset colorectal cancer.

High-fat diet plus HNF1A variant promotes polyps by activating β-catenin in early-onset colorectal cancer.

Journal: JCI insight
Published: November 21, 2022
Showing 1-12 of 56

Last Updated: 09/26/2026